Gender-specific prevalence and associated risk factors of prehypertension among rural children and a

来源 :第十二届中国介入心脏病学大会(CIT2014) | 被引量 : 0次 | 上传用户:FollowMyHeart88
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Little is known about the prevalence and risk profile of prehypertension among Chinese children and adolescents.The aim of the present study was to investigate the prehypertensive status and its associated risk factors among rural Chinese children and adolescents.
其他文献
Background To evaluate the effects of trimetazidine on left ventricular function and thehibemafing myocardium by 18FDG PET-CT in patients with ischemic cardiomyopathy.Methods 60 cases with ischemic ca
会议
Background The feasibility,efficacy and safety of transradial (TR) versus transfemoral (TF) methods of percutaneous coronary intervention (PCI) for unprotected left main coronary artery (ULMCA) diseas
会议
Background Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) implantation has been considered an altemative therapy to cardiac surgery for left main (LM) patients with low to mod
会议
Background Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) implantation has been considered an alternative therapy to cardiac surgery for left main (LM) patients with low to mo
会议
Background Clopidogrel and statin are strongly recommended after percutaneous coronary intervention,and administration of high dose statin can notably improve prognosis in elder patients with high ris
会议
Background Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is still challenging especially in small coronary arteries.The intention of this sub-group analysis is to compare the safety an
会议
Background Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is still challenging especially in diffuse lesions.The intention of this subgroup analysis is to compare the safety and effecti
会议
Background Twelve-month dual antiplatelet therapy (DAT) with aspirin and clopidogrel after drug-eluting stent (DES) implantation is routinely recommended.It is unclear if prolonged (> 12 months) DAT i
会议
Background The combination of clopidogrel added proton pump inhibitors after a percutaneous coronary intervention has been used in clincal therapy,but whether it is safe and effective should be furthe
会议
Background TARGET Ⅰ randomized controlled trial demonstrated that the novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent FIREHAWK (MicroPort Medical,Shanghai,China) was non-in
会议